Stock Events

Stock Events

Clinuvel Pharmaceuticals (CUV.AU) Q3 2024 Earnings

CUV.AU
Aug 28Confirmed
Q1 2023
Q3 2023
Q1 2024
Q3 2024
0.21
0.3
0.39
0.49

Details

Expected EPS
0.43279143762434596
Actual EPS
0.48530012526711364
Surprise EPS
0.05
Surprise Percent
+12.13%

Description

⁨Clinuvel Pharmaceuticals⁩ (⁦CUV.AU⁩) has reported earnings of ⁦0.48530012526711364⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts